期刊文献+

高血糖与帕金森病的关系 被引量:1

Hyperglycemia and Parkinson's Disease
下载PDF
导出
摘要 帕金森病又称震颤麻痹,是中老年人最常见的中枢神经系统变性疾病。主要是因位于中脑部位"黑质"中的细胞发生病理性改变后,多巴胺的合成减少,抑制乙酰胆碱的功能降低,则乙酰胆碱的兴奋作用相对增强。两者失衡的结果便出现了"震颤麻痹"。短时间、一次性的高血糖对人体无严重损害,然而长期的高血糖会使全身各个组织器官发生病变,导致急慢性并发症的发生。众多研究显示高血糖可能与帕金森病有关,本文就高血糖与帕金森病的关系进行综述。 Parkinson's disease, also known as paralysis agitans, is the most common degenerative diseases of the cen- tral nervous system in elderly. Its main reason is that dopamine synthesis and the function inhibiting acetylcholine are reduced, while the excitatory effect of acetylcholine relatively enhanced after the pathological changes of cells in substantia nigra of Pars mesencephalica. The imbalance between them results in " Shaking Palsy". Short time or one - time hyperglycemia is of no seri- ous damage to human body, but the long - term would cause lesions in various tissues and organs, leading to acute or chronic complications. Many studies show that hyperglycemia may be related to Parkinson's disease. This article reviews the relationship of hyperglycemia to Parkinson's disease.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第2期210-212,共3页 Chinese General Practice
关键词 帕金森病 糖尿病 高血糖症 Parkinson's disease Diabetes mellitus Hyperglycemia
  • 相关文献

参考文献18

  • 1Zhang ZX, Anderson DW, Huang JB, et al. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China [ J ]. Movement Disorders, 2003, 18 (7): 764-772.
  • 2Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism [J]. Neurology, 2003, 60: 87-93.
  • 3Smith .IL, Ju JS, Saha BM, et al. Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin -stimulated glucose transport in rat skeletal muscle[J].J Appl Physiol, 2004, 97: 2339 - 2346.
  • 4Arvanitakis Z, Wilson RS, Schneider JA, et al. diabetes mellitus and progression of rigidity and gait disturbance in older persons [J]. Neurology, 2004, 63: 996-1001.
  • 5Gang Hu, Pekka, Siamak, et al. Type 2 diabetes and the risk of parkinson's disease[J]. Diabetes Care, 2007, 30: 842-847.
  • 6Wilson RS, Schneider JA, Bienias LL, et al. Parkinsonian - like signs and risk of incident Mzheimer disease in older persons [J]. Arch Neurol, 2003, 60:539 -544.
  • 7Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes [ J ]. Dia betes, 2004, 53 (Suppl1): S110-118.
  • 8Owen AM, Doyon J, Dagher A, et al. Abnormal basal ganglia outflow in Parkinson' disease identified with PET implications for higher cortical functions [ J]. Brain, 1998, 121: 949 - 965.
  • 9Antonini A, Kazumata K, Feigin A, et al. Differemial diagnosis of Parkinson with 18F - fluorodeoxyglueose and PET [ J ]. Mov Disord, 1998, 13: 268-274.
  • 10王丽娟,唐安戊,刘斌,郑芷萍,周晓红,乔穗宪,刘新通,詹国华,梁秀龄.帕金森病脑^(18)F-FDG PET显像临床研究[J].中华核医学杂志,2002,22(1):17-18. 被引量:15

二级参考文献18

  • 1陈生弟,周孝达,徐德隆,朱承谟,张冀先,国毓智,匡琴芳,李彪.偏侧帕金森病猴模型的脑血流灌注SPECT在体显像研究[J].中华核医学杂志,1994,14(4):209-210. 被引量:14
  • 2王新德.帕金森病及帕金森综合征的诊断标准和鉴别诊断[J].中华神经精神科杂志,1985,18(4):256-256.
  • 3T Annanmaki, A Pessala-Driver, L Hokkanen et al. Parkinsonism Relat Disord,, 2008, (3) :1 - 3,
  • 4G Hu, P Jousilahti, S Bidel et al. Diabetes Care, 2007, (40) : 842 - 847.
  • 5J D Braunstein, M Halwer. Clin Chem., 1986, 32(8):1588 - 1589.
  • 6D W Song, Q Li, Y J Luan et al. Complex Medical Engineering, 2007. CME 2007. IEEE/ICME Intl, Conf. on 23-27. 2007:1817 - 1823,
  • 7C W Olanow. Mov. Disord,, 2007, (17) : 335 - 342.
  • 8S Li, M Mallory, M Alford et al. J. Neuropathol. Exp. Neurol,, 1997, 56(8) :901 - 911.
  • 9K S Saravanan, K M Sindhu, K P Mohanakumar, J, Pineal, Res., 2007, 42(3) :247 - 253.
  • 10Y Han, E Randell, S Vasdev et al. Mol. Cell. Biochem., 2007, 305(1-2):123 -131.

共引文献22

同被引文献19

  • 1Tuomiletho J, Rastenyte D, Jousilahti P, et al. Diabetes mellitus as a risk factor for death from stroke; prospective study of the middle- aged Finnish population[ J]. Stroke, 1996, 27 : 210.
  • 2Leibson CL, Rossa WA, Hanson VA, et al. The risk of dementia a- mong person with diabetes mellitus: a population-based cohort study [J]. Ann N Y Acad Sci, 1997, 826: 422.
  • 3Gibson EL. Emotional influences on food choice: sensory, physio- logical and psychological pathways [ J]. Physiol Behav, 2006, 89: 53.
  • 4Driver JA, Smith A, Buring JE, et al. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease [ J]. Diabetes Care, 2008, 31 : 2003.
  • 5Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impair- ment--beyond controversies, towards a consensus: report of the In- ternational Working Group on Mild Cognitive Impairment [ J]. J In- tern Med, 2004, 256: 240.
  • 6Wilson RS, Schneider JA, Bienias LL, et al. Parkinsonian-like signs and risk of incident Alzheimer disease in older persons [ J ]. Arch Neural, 2003, 60: 539.
  • 7Hu G, Jousilahti P, Bidel S, et al. Type2 diabetes and the risk of Parkinson's disease [ J ]. Diabetes Care, 2007, 30 : 842.
  • 8Simon KC, Chen H, Schwarzschild M, et al. Hypertension, hyper- cholesterolemia, diabetes, and risk of Parkinson disease [ J ]. Neu- rology, 2007, 69: 1688.
  • 9Powers KM, Smith-Weller T, Franklin GA, et al. Diabetes, smok- ing, and other medical conditions in relation to Parkinso's disease risk [ J ]. Parkinsonism Relat Disord, 2006, 12 : 185.
  • 10aCereda E, Barichella M, Cassani E. Clinical features of Parkinson disease when onset of diabetes came first cL case-control study [ J ]. Neurology, 2012, 78 : 1507.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部